1999
DOI: 10.1016/s0028-3908(99)00125-2
|View full text |Cite
|
Sign up to set email alerts
|

Functional characterization and expression of thalamic GABAB receptors in a rodent model of Parkinson's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
1

Year Published

2001
2001
2021
2021

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(4 citation statements)
references
References 42 publications
0
3
1
Order By: Relevance
“…While an increase in the expression of GABA-B receptors in the parkinsonian state could account for this difference, the available evidence indicates either no change (current report, and de Groote et al, 1999) or even a downregulation of GPe GABA-B receptors binding (Calon et al, 2003) in parkinsonism. Alternatively, the coupling of these receptors to G-protein effectors or their assembly to auxiliary units (Schwenk et al, 2010) could be potentiated after dopamine depletion, resulting in enhanced responses to activation.…”
Section: Discussioncontrasting
confidence: 50%
“…While an increase in the expression of GABA-B receptors in the parkinsonian state could account for this difference, the available evidence indicates either no change (current report, and de Groote et al, 1999) or even a downregulation of GPe GABA-B receptors binding (Calon et al, 2003) in parkinsonism. Alternatively, the coupling of these receptors to G-protein effectors or their assembly to auxiliary units (Schwenk et al, 2010) could be potentiated after dopamine depletion, resulting in enhanced responses to activation.…”
Section: Discussioncontrasting
confidence: 50%
“…The possibility that thalamic GABA B receptors play a role in PD is supported by results showing that the GABA B agonist baclofen induces akinesia when administrated locally in the ventromedial (VM) nucleus of the thalamus (DiChiara et al, 1979; Klockgether et al, 1986; Wullner et al, 1987). However, blockade of GABA B receptors in the VM of unilatelarally 6‐hydroxydopamine‐lesioned rats does not have any effects on rotational behavior (de Groote et al, 1999), and binding studies could not find any significant changes in the number of GABA B binding sites in the thalamic ventral motor nuclei of MPTP‐treated parkinsonian monkeys (Calon et al, 2000). Modulation of glutamatergic neurotransmission has beneficial effects in PD.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, changes in trafficking may produce the sensitized response to GABA B signalling that is seen in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐treated monkeys (Galvan et al ., ), as no increases in GABA B receptor expression have been noted in human patients with PD (de Groote et al ., ) or MPTP‐treated monkeys (Galvan et al ., ). It is tempting to speculate that the minority of GPe neurons that display a significant outward postsynaptic current in response to baclofen in the healthy state (Chen et al ., ) corresponds to the Npas1 + GPe neuron population (Hernandez et al ., ), and that the decrease in pacemaking of GPe neurons seen in 6‐OHDA‐lesioned mice (Chan et al ., ; Hernandez et al ., ) may be attributable to a sensitized GABA B response.…”
Section: Synaptic and Neuromodulatory Control Of The Gpementioning
confidence: 97%